FREE EXPRESS SHIPPING ON AUSTRALIAN ORDERS OVER $150|SYDNEY, AUSTRALIA|RESEARCH USE ONLYFREE EXPRESS OVER $150|RESEARCH USE ONLY
← Research Library

Citations

Reference records cited by this library, with the guides that cite them and source links where recorded. The collection includes different types of sources. Inclusion records a citation; it does not establish the accuracy or quality of a source.

234
reference records, from 393 citations across 99 guides
45
cited by more than one guide
1902–2025
publication years represented
0
with no link recorded, shown and marked

How this list is built

  • Source-record audit: 25 September 2026. Incorrect links and bibliographic details have been corrected where a source record was established. Unresolved references, an identified retraction and an expression of concern carry visible source notes; linked corrections are also shown. This checks publication details; it does not establish that each guide claim is supported by the cited work.
  • Records are currently grouped by recorded URL. 393 citations resolve to 234 rows. Different URLs can identify the same publication, so this is not a verified count of distinct works. Publication-level reconciliation is pending.
  • References without a link are shown, not hidden. 0 records have no link entered in the guide data. This does not establish that no online record exists. They remain separate rows pending bibliographic verification; some may describe the same work.
  • Records cited by several guides can be viewed separately. 45 records are associated with two or more guides. Repeated citation within this library is not a measure of scientific quality or independent support.
  • It is derived, not maintained. This page reads the reference lists in the guides themselves, so it cannot drift from them. Add a reference to a guide and it appears here.

Exports include only matching records and preserve source-review and correction notes. BibTeX and RIS include structured authors and source types where verified against source records; journal articles are not necessarily original studies. Original author text remains in notes. Where structured names are unavailable, check and complete the author fields before using an imported citation.

View
Order
Research area

Showing 234 reference records.

  1. 2025Cited by 4 guides

    Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.

    Araj SK, Brzezik J, Mądra-Gackowska K, et al. · International journal of molecular sciences

  2. 2025

    Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.

    Al-Dulaimi S, Thomas R, Matta S, et al. · Biogerontology

    The publisher replaced Figures 1, 2 and 3 in a correction published in November 2025. Interpret the cell-line findings using the corrected figures; they are not clinical efficacy evidence. View notice

    Cited by: Epitalon
  3. 2025

    Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development.

    Ullah S, Haider Z, Perera CD, et al. · Life sciences

    Cited by: Epitalon
  4. 2025

    Triple Agonism Based Therapies for Obesity.

    Goldney J, Hamza M, Surti F, et al. · Current cardiovascular risk reports

    Cited by: Retatrutide
  5. 2024

    Biochemistry, Essential Amino Acids (Archived).

    Lopez MJ, Mohiuddin SS. · StatPearls, NCBI Bookshelf

  6. 2024

    Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial.

    le Roux CW, Steen O, Lucas KJ, et al. · The lancet. Diabetes & endocrinology

    A correction is linked in PubMed. The full correction text was not verified in this review, so its effect on the cited claims remains unresolved. View notice

  7. 2024

    Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

    Sanyal AJ, Kaplan LM, Frias JP, et al. · Nature medicine

    Cited by: Retatrutide
  8. 2023Cited by 4 guides

    Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

    Jastreboff AM, Kaplan LM, Frías JP, et al. · The New England journal of medicine

  9. 2023

    Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.

    Frias JP, Deenadayalan S, Erichsen L, et al. · Lancet (London, England)

    Cited by: Cagrilintide
  10. 2023

    Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

    Rosenstock J, Frias J, Jastreboff AM, et al. · Lancet (London, England)

    Cited by: Retatrutide
  11. 2023

    Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

    Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. · The New England journal of medicine

    Cited by: Semaglutide
  12. 2023

    Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models.

    Zonari A, Brace LE, Al-Katib K, et al. · npj aging

    The 2024 correction replaces an unintentionally duplicated image in Figure 6a. The authors state that the correction does not change their main conclusions. View notice

  13. 2022Cited by 3 guides

    Tirzepatide Once Weekly for the Treatment of Obesity.

    Jastreboff AM, Aronne LJ, Ahmad NN, et al. · The New England journal of medicine

  14. 2022Cited by 2 guides

    Therapeutic peptides: current applications and future directions.

    Wang L, Wang N, Zhang W, et al. · Signal transduction and targeted therapy

  15. 2022

    LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

    Coskun T, Urva S, Roell WC, et al. · Cell metabolism

    Cited by: Retatrutide
  16. 2022

    Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.

    He L, Feng D, Guo H, et al. · Frontiers in Pharmacology

  17. 2021Cited by 3 guides

    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

    Frías JP, Davies MJ, Rosenstock J, et al. · The New England journal of medicine

  18. 2021Cited by 2 guides

    Lehninger Principles of Biochemistry (Chapter 3: Amino Acids, Peptides, and Proteins).

    Nelson DL, Cox MM, Hoskins A. · W. H. Freeman, 8th ed.

  19. 2021Cited by 2 guides

    Once-Weekly Semaglutide in Adults with Overweight or Obesity.

    Wilding JPH, Batterham RL, Calanna S, et al. · The New England journal of medicine

  20. 2021

    Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria.

    Wensink D, Wagenmakers MAEM, Langendonk JG. · Expert review of clinical pharmacology

    Cited by: Melanotan-1
  21. 2021

    AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.

    Sun X, Deng Y, Fu X, et al. · Brain sciences

    Cited by: Dihexa
  22. 2021

    Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial.

    Heymsfield SB, Coleman LA, Miller R, et al. · JAMA network open

    Two February 2021 corrections address the Discussion, HbA1c reporting and Table 2. Consult both notices (PMIDs 33576812 and 33646308) before using numerical results. View notice

  23. 2021

    Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis.

    de Miranda RB, Weimer P, Rossi RC. · International journal of dermatology

  24. 2021

    Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.

    Rosenstock J, Wysham C, Frías JP, et al. · Lancet (London, England)

    A correction is linked in PubMed. The full correction text was not verified in this review, so its effect on the cited claims remains unresolved. View notice

    Cited by: Tirzepatide
  25. 2021

    MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.

    Reynolds JC, Lai RW, Woodhead JST, et al. · Nature communications

    Cited by: MOTS-c
  26. 2021

    NAD(+) metabolism and its roles in cellular processes during ageing.

    Covarrubias AJ, Perrone R, Grozio A, et al. · Nature reviews. Molecular cell biology

  27. 2021

    Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.

    Lau DCW, Erichsen L, Francisco AM, et al. · Lancet (London, England)

    Cited by: Cagrilintide
  28. 2021

    Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.

    Ludvik B, Giorgino F, Jódar E, et al. · Lancet (London, England)

    Cited by: Tirzepatide
  29. 2021

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.

    Enebo LB, Berthelsen KK, Kankam M, et al. · Lancet (London, England)

    Cited by: Cagrilintide
  30. 2021

    Sortilin-derived peptides promote pancreatic beta-cell survival through CREB signaling pathway.

    Daziano G, Blondeau N, Béraud-Dufour S, et al. · Pharmacological research

    Cited by: PE-22-28
  31. 2021

    Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies.

    Maar K, Hetenyi R, Maar S, et al. · Cells

    Cited by: TB-500
  32. 2020Cited by 2 guides

    Senolytic drugs: from discovery to translation.

    Kirkland JL, Tchkonia T. · Journal of internal medicine

  33. 2020

    EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

    Khavinson V, Linkova N, Kozhevnikova E, et al. · Molecules (Basel, Switzerland)

    Cited by: Pinealon
  34. 2020

    Gonadotropin-releasing hormone (GnRH) agonist implants for male dog fertility suppression: a review of mode of action, efficacy, safety, and uses.

    Driancourt MA, Briggs JR. · Frontiers in Veterinary Science

  35. 2020

    Growth hormone secretagogues: history, mechanism of action, and clinical development.

    Ishida J, et al. · JCSM Rapid Communications

    Cited by: Ipamorelin
  36. 2020

    How May GIP Enhance the Therapeutic Efficacy of GLP-1?

    Samms RJ, Coghlan MP, Sloop KW. · Trends in endocrinology and metabolism: TEM

  37. 2020

    Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.

    Filippenkov IB, Stavchansky VV, Denisova AE, et al. · Genes

    Cited by: Semax
  38. 2020

    Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.

    Willard FS, Douros JD, Gabe MB, et al. · JCI insight

    Cited by: Tirzepatide
  39. 2019Cited by 3 guides

    Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

    Kingsberg SA, Clayton AH, Portman D, et al. · Obstetrics and gynecology

  40. 2019Cited by 3 guides

    The Discovery and Development of Liraglutide and Semaglutide.

    Knudsen LB, Lau J. · Frontiers in endocrinology

  41. 2019

    Effect of Peptide AEDG on Telomere Length and Mitotic Index of PHA-Stimulated Human Blood Lymphocytes.

    Khavinson VK, Pendina AA, Efimova OA, et al. · Bulletin of experimental biology and medicine

    Cited by: Epitalon
  42. 2019

    Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin.

    Djillani A, Pietri M, Mazella J, et al. · Pharmacology & therapeutics

    Cited by: PE-22-28
  43. 2019

    First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides.

    Pietri M, Djillani A, Mazella J, et al. · Neuropharmacology

    Cited by: PE-22-28
  44. 2019

    MOTS-c: an equal opportunity insulin sensitizer.

    Kim SJ, Miller B, Kumagai H, et al. · Journal of molecular medicine (Berlin, Germany)

    Cited by: MOTS-c
  45. 2019

    Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.

    Iwasaki M, Akiba Y, Kaunitz JD. · F1000Research

  46. 2018Cited by 5 guides

    The Safety and Efficacy of Growth Hormone Secretagogues.

    Sigalos JT, Pastuszak AW. · Sexual medicine reviews

  47. 2018Cited by 4 guides

    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.

    Pickart L, Margolina A. · International journal of molecular sciences

  48. 2018Cited by 3 guides

    Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

    Drucker DJ. · Cell metabolism

  49. 2018

    BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.

    Seiwerth S, Rucman R, Turkovic B, et al. · Current pharmaceutical design

    Cited by: BPC-157
  50. 2018

    Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults.

    Martens CR, Denman BA, Mazzo MR, et al. · Nature communications

  51. 2018

    Incretin hormones: Their role in health and disease.

    Nauck MA, Meier JJ. · Diabetes, obesity & metabolism

  52. 2018

    The Oxytocin Receptor: From Intracellular Signaling to Behavior.

    Jurek B, Neumann ID. · Physiological reviews

    Cited by: Oxytocin
  53. 2018

    Therapeutic peptides: Historical perspectives, current development trends, and future directions.

    Lau JL, Dunn MK. · Bioorganic & medicinal chemistry

  54. 2018

    Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

    Rajman L, Chwalek K, Sinclair DA. · Cell metabolism

  55. 2017Cited by 3 guides

    Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.

    Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, et al. · Clinical Medicine Insights. Cardiology

    Cited by: GHRP-2, GHRP-6, Hexarelin
  56. 2017Cited by 2 guides

    Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

    Kasian A, Kolomin T, Andreeva L, et al. · Behavioural neurology

  57. 2017Cited by 2 guides

    Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.

    Baar MP, Brandt RMC, Putavet DA, et al. · Cell

  58. 2017

    Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.

    Culver DA, Dahan A, Bajorunas D, et al. · Investigative ophthalmology & visual science

    Cited by: ARA-290
  59. 2017

    GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

    Filatova E, Kasian A, Kolomin T, et al. · Frontiers in pharmacology

    Cited by: Selank
  60. 2017

    Guidance on the use of International Nonproprietary Names (INNs) for pharmaceutical substances.

    World Health Organization. · WHO Programme on INN

  61. 2017

    Mitochondrially derived peptides as novel regulators of metabolism.

    Kim SJ, Xiao J, Wan J, et al. · The Journal of physiology

  62. 2017

    Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.

    Xiao B, Xu Z, Viennois E, et al. · Molecular therapy : the journal of the American Society of Gene Therapy

    Cited by: KPV
  63. 2017

    Overview of Neuropeptides: Awakening the Senses?

    Russo AF. · Headache

  64. 2017

    Senescent cells: an emerging target for diseases of ageing.

    Childs BG, Gluscevic M, Baker DJ, et al. · Nature reviews. Drug discovery

    Cited by: FOXO4-DRI
  65. 2017

    Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.

    Djillani A, Pietri M, Moreno S, et al. · Frontiers in pharmacology

    Cited by: PE-22-28
  66. 2017

    Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.

    Pawar K, Kolli CS, Rangari VK, et al. · Journal of pharmaceutical sciences

    Cited by: KPV
  67. 2017

    β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis.

    Saunders B, Elliott-Sale K, Artioli GG, et al. · British journal of sports medicine

    Cited by: Carnosine
  68. 2016Cited by 2 guides

    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

    Marso SP, Bain SC, Consoli A, et al. · The New England journal of medicine

  69. 2016

    Advances in Fmoc solid-phase peptide synthesis.

    Behrendt R, White P, Offer J. · Journal of peptide science : an official publication of the European Peptide Society

  70. 2016

    MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism.

    Lee C, Kim KH, Cohen P. · Free radical biology & medicine

    Cited by: MOTS-c
  71. 2016

    Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

    Volkova A, Shadrina M, Kolomin T, et al. · Frontiers in pharmacology

    Cited by: Selank
  72. 2015Cited by 3 guides

    Afamelanotide for Erythropoietic Protoporphyria.

    Langendonk JG, Balwani M, Anderson KE, et al. · The New England journal of medicine

  73. 2015Cited by 3 guides

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

    Lee C, Zeng J, Drew BG, et al. · Cell metabolism

  74. 2015Cited by 2 guides

    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.

    Pickart L, Vasquez-Soltero JM, Margolina A. · BioMed research international

  75. 2015

    Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.

    Lim HW, Grimes PE, Agbai O, et al. · JAMA dermatology

    Cited by: Melanotan-1
  76. 2015

    Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria.

    Biolcati G, Marchesini E, Sorge F, et al. · The British journal of dermatology

    Cited by: Melanotan-1
  77. 2015

    Peptides and the blood-brain barrier.

    Banks WA. · Peptides

  78. 2015

    Randomized controlled trial of oral glutathione supplementation on body stores of glutathione.

    Richie JP Jr, Nichenametla S, Neidig W, et al. · European journal of nutrition

    Cited by: Glutathione
  79. 2015

    The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease.

    Wright JW, Harding JW. · Journal of Alzheimer's disease : JAD

    Cited by: Dihexa
  80. 2014Cited by 2 guides

    The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.

    Medvedeva EV, Dmitrieva VG, Povarova OV, et al. · BMC genomics

  81. 2014

    Clinical use of deslorelin (GnRH agonist) in companion animals: a review.

    Lucas X. · Reproduction in domestic animals = Zuchthygiene

  82. 2014

    Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

    Stanley TL, Feldpausch MN, Oh J, et al. · JAMA

    Cited by: Tesamorelin
  83. 2014

    First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

    Szeto HH. · British journal of pharmacology

    Cited by: SS-31
  84. 2014

    GHK and DNA: resetting the human genome to health.

    Pickart L, Vasquez-Soltero JM, Margolina A. · BioMed research international

    Cited by: GHK-Cu
  85. 2014

    Melanoma associated with the use of melanotan-II.

    Hjuler KF, Lorentzen HF. · Dermatology (Basel, Switzerland)

    Cited by: Melanotan II
  86. 2014

    Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study.

    Proksch E, Segger D, Degwert J, et al. · Skin pharmacology and physiology

  87. 2014

    Peptide regulation of gene expression and protein synthesis in bronchial epithelium.

    Khavinson VKh, Tendler SM, Vanyushin BF, et al. · Lung

    Cited by: Pinealon
  88. 2014

    Preclinical research: Make mouse studies work.

    Perrin S. · Nature

  89. 2014

    Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.

    Bolognin S, Buffelli M, Puoliväli J, et al. · Neurobiology of aging

    Cited by: P21 (Peptide)
  90. 2014

    Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health.

    Moré MI, Kenley D. · Journal of Endocrinology and Metabolism

    Cited by: AOD-9604
  91. 2014

    The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

    Benoist CC, Kawas LH, Zhu M, et al. · The Journal of pharmacology and experimental therapeutics

    Source review: Retracted publication. PubMed records a 2025 retraction (PMID 40312093). This paper must not be treated as supporting evidence; claims relying on it require reassessment.

    View notice

    Cited by: Dihexa
  92. 2014

    The role of senescent cells in ageing.

    van Deursen JM. · Nature

    Cited by: FOXO4-DRI
  93. 2014

    Using Copper to Improve the Well-Being of the Skin.

    Borkow G. · Current chemical biology

  94. 2013Cited by 2 guides

    Humanin: a harbinger of mitochondrial-derived peptides?

    Lee C, Yen K, Cohen P. · Trends in endocrinology and metabolism: TEM

  95. 2013

    A new generation of drugs: synthetic peptides based on natural regulatory peptides.

    Kolomin T, Shadrina M, Slominsky P, et al. · Neuroscience and Medicine

    Cited by: Semax vs Selank
  96. 2013

    ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.

    Dahan A, Dunne A, Swartjes M, et al. · Molecular medicine (Cambridge, Mass.)

    The 2016 erratum corrects the corneal nerve fibre area calculation: reported areas require a factor of 2.26, with a further factor of 6.32 for the stated normalisation. Use the corrected source for these values. View notice

    Cited by: ARA-290
  97. 2013

    Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.

    McCoy AT, Benoist CC, Wright JW, et al. · The Journal of pharmacology and experimental therapeutics

    Source review: Expression of concern. PubMed links an editorial concern notice (PMID 34551989) to this paper; interpret claims relying on it with that notice in view.

    View notice

    Cited by: Dihexa
  98. 2013

    Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides.

    Dai DF, Hsieh EJ, Chen T, et al. · Circulation. Heart failure

    Cited by: SS-31
  99. 2013

    Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice.

    Siegel MP, Kruse SE, Percival JM, et al. · Aging cell

    Cited by: SS-31
  100. 2013

    Physiology and pathophysiology of carnosine.

    Boldyrev AA, Aldini G, Derave W. · Physiological reviews

    Cited by: Carnosine
  101. 2013

    Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans.

    Stier H, Vos E, Kenley D. · Journal of Endocrinology and Metabolism

    Cited by: AOD-9604
  102. 2013

    The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study.

    Wang Y, Wang M, Xiao S, et al. · American journal of clinical dermatology

  103. 2013

    The emerging role of the mitochondrial-derived peptide humanin in stress resistance.

    Yen K, Lee C, Mehta H, et al. · Journal of molecular endocrinology

    Cited by: Humanin
  104. 2013

    The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

    Birk AV, Liu S, Soong Y, et al. · Journal of the American Society of Nephrology : JASN

    Cited by: SS-31
  105. 2013

    Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.

    Sikiric P, Seiwerth S, Rucman R, et al. · Current pharmaceutical design

    Cited by: BPC-157
  106. 2013

    Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

    Delgado M, Ganea D. · Amino acids

  107. 2012

    Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.

    Neumann ID, Landgraf R. · Trends in neurosciences

    Cited by: Oxytocin
  108. 2012

    Caregiver placebo effect for dogs with lameness from osteoarthritis.

    Conzemius MG, Evans RB. · Journal of the American Veterinary Medical Association

  109. 2012

    Drug development: Raise standards for preclinical cancer research.

    Begley CG, Ellis LM. · Nature

  110. 2012

    Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus.

    Greenwood-Van Meerveld B, Tyler K, Mohammadi E, et al. · Journal of experimental pharmacology

    Cited by: Ipamorelin
  111. 2012

    Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

    Stanley TL, Falutz J, Marsolais C, et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

  112. 2012

    Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy.

    Spooner LM, Olin JL. · The Annals of pharmacotherapy

    Cited by: Tesamorelin
  113. 2012

    The receptor that tames the innate immune response.

    Brines M, Cerami A. · Molecular medicine (Cambridge, Mass.)

    Cited by: ARA-290
  114. 2012

    Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.

    Goldstein AL, Hannappel E, Sosne G, et al. · Expert opinion on biological therapy

    Cited by: TB-500
  115. 2011Cited by 18 guides

    Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.

    Fedoreyeva LI, Kireev II, Khavinson VKh, et al. · Biochemistry. Biokhimiia

  116. 2011Cited by 2 guides

    Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.

    Sikiric P, Seiwerth S, Rucman R, et al. · Current pharmaceutical design

  117. 2011

    Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide.

    Chohan MO, Li B, Blanchard J, et al. · Neurobiology of aging

    Cited by: P21 (Peptide)
  118. 2011

    Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

    Meyer-Lindenberg A, Domes G, Kirsch P, et al. · Nature reviews. Neuroscience

    Cited by: Oxytocin
  119. 2011

    Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.

    Dhillon S. · Drugs

    Cited by: Tesamorelin
  120. 2011

    The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

    Lillie EO, Patay B, Diamant J, et al. · Personalized medicine

  121. 2011

    The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

    Chang CH, Tsai WC, Lin MS, et al. · Journal of applied physiology (Bethesda, Md. : 1985)

    Cited by: BPC-157
  122. 2011

    What are neuropeptides?

    Burbach JP. · Methods in molecular biology (Clifton, N.J.)

  123. 2010Cited by 25 guides

    Peptide bioregulation of aging: results and prospects.

    Anisimov VN, Khavinson VKh. · Biogerontology

  124. 2010

    Biological functions of hCG and hCG-related molecules.

    Cole LA. · Reproductive biology and endocrinology : RB&E

    Cited by: HCG
  125. 2010

    Biological, clinical, and ethical advances of placebo effects.

    Finniss DG, Kaptchuk TJ, Miller F, et al. · Lancet (London, England)

  126. 2010

    CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

    Schulz KF, Altman DG, Moher D. · BMC medicine

  127. 2010

    Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration.

    Matheny RW Jr, Nindl BC, Adamo ML. · Endocrinology

    Cited by: MGF and PEG-MGF
  128. 2010

    Placebos without deception: a randomized controlled trial in irritable bowel syndrome.

    Kaptchuk TJ, Friedlander E, Kelley JM, et al. · PloS one

  129. 2010

    Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.

    Dmitrieva VG, Povarova OV, Skvortsova VI, et al. · Cellular and molecular neurobiology

    Cited by: Semax
  130. 2010

    The senescence-associated secretory phenotype: the dark side of tumor suppression.

    Coppé JP, Desprez PY, Krtolica A, et al. · Annual review of pathology

  131. 2009

    Copper-GHK increases integrin expression and p63 positivity by keratinocytes.

    Kang YA, Choi HR, Na JI, et al. · Archives of dermatological research

    Cited by: GHK-Cu
  132. 2009

    Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus.

    Venkova K, Mann W, Nelson R, et al. · The Journal of pharmacology and experimental therapeutics

    Cited by: Ipamorelin
  133. 2009

    Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.

    Kota J, Handy CR, Haidet AM, et al. · Science translational medicine

    A correction is linked in PubMed. The full correction text was not verified in this review, so its effect on the cited claims remains unresolved. View notice

    Cited by: Follistatin-344
  134. 2009

    Glutathione: overview of its protective roles, measurement, and biosynthesis.

    Forman HJ, Zhang H, Rinna A. · Molecular aspects of medicine

    Cited by: Glutathione
  135. 2009

    p21 in cancer: intricate networks and multiple activities.

    Abbas T, Dutta A. · Nature reviews. Cancer

    Cited by: P21 (Peptide)
  136. 2009

    The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

    Reggiani PC, Morel GR, Cónsole GM, et al. · Annals of the New York Academy of Sciences

    Cited by: Thymulin
  137. 2008Cited by 2 guides

    [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

    Zozulia AA, Neznamov GG, Siuniakov TS, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

  138. 2008

    Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

    Nass R, Pezzoli SS, Oliveri MC, et al. · Annals of internal medicine

  139. 2008

    Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.

    Brines M, Patel NS, Villa P, et al. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: ARA-290
  140. 2008

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

    Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. · Gastroenterology

    Cited by: KPV
  141. 2008

    Wound repair and regeneration.

    Gurtner GC, Werner S, Barrandon Y, et al. · Nature

  142. 2007Cited by 2 guides

    Metabolic effects of a growth hormone-releasing factor in patients with HIV.

    Falutz J, Allas S, Blot K, et al. · The New England journal of medicine

  143. 2007Cited by 2 guides

    Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.

    Sosne G, Qiu P, Kurpakus-Wheater M. · Clinical ophthalmology (Auckland, N.Z.)

  144. 2007

    alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.

    Luger TA, Brzoska T. · Annals of the rheumatic diseases

    Cited by: KPV
  145. 2007

    Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

    Gonzalez-Rey E, Delgado M. · Trends in pharmacological sciences

  146. 2007

    Antioxidant properties of geroprotective peptides of the pineal gland.

    Kozina LS, Arutjunyan AV, Khavinson VKh. · Archives of gerontology and geriatrics

  147. 2007

    beta-Thymosins.

    Hannappel E. · Annals of the New York Academy of Sciences

  148. 2007

    Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer.

    Clemmons DR. · Nature reviews. Drug discovery

    Cited by: IGF-1 LR3
  149. 2007

    Thymosin alpha1: a historical overview.

    Garaci E. · Annals of the New York Academy of Sciences

  150. 2006Cited by 5 guides

    Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

    Teichman SL, Neale A, Lawrence B, et al. · The Journal of clinical endocrinology and metabolism

  151. 2006Cited by 4 guides

    Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

    Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain research

  152. 2006Cited by 2 guides

    Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

    Ionescu M, Frohman LA. · The Journal of clinical endocrinology and metabolism

  153. 2006

    Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation.

    Krivic A, Anic T, Seiwerth S, et al. · Journal of orthopaedic research : official publication of the Orthopaedic Research Society

    Cited by: BPC-157
  154. 2006

    An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.

    Diamond LE, Earle DC, Heiman JR, et al. · The journal of sexual medicine

    Cited by: PT-141
  155. 2006

    Delta sleep-inducing peptide (DSIP): a still unresolved riddle.

    Kovalzon VM, Strekalova TV. · Journal of neurochemistry

    Cited by: DSIP
  156. 2006

    LL-37, the only human member of the cathelicidin family of antimicrobial peptides.

    Dürr UH, Sudheendra US, Ramamoorthy A. · Biochimica et biophysica acta

    Cited by: LL-37
  157. 2006

    Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

    Hadley ME, Dorr RT. · Peptides

    Cited by: Melanotan II
  158. 2006

    Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

    Alba M, Fintini D, Sagazio A, et al. · American journal of physiology. Endocrinology and metabolism

    Cited by: CJC-1295 No DAC
  159. 2006

    Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?

    Walker RF. · Clinical interventions in aging

    Cited by: Sermorelin
  160. 2006

    Strategies to improve plasma half life time of peptide and protein drugs.

    Werle M, Bernkop-Schnürch A. · Amino acids

  161. 2006

    Studies on the physiological functions of the melanocortin system.

    Cone RD. · Endocrine reviews

  162. 2006

    The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis.

    Harris RC, Tallon MJ, Dunnett M, et al. · Amino acids

    Cited by: Carnosine
  163. 2006

    The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists.

    Fares F. · Biochimica et biophysica acta

    Cited by: HCG
  164. 2005Cited by 22 guides

    Gerontological Aspects of Genome Peptide Regulation.

    Khavinson VK, Malinin VV. · Karger AG, Basel

  165. 2005Cited by 3 guides

    Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues.

    Goldstein AL, Hannappel E, Kleinman HK. · Trends in molecular medicine

  166. 2005

    Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

    Jetté L, Léger R, Thibaudeau K, et al. · Endocrinology

  167. 2005

    Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates.

    Iwai K, Hasegawa T, Taguchi Y, et al. · Journal of agricultural and food chemistry

  168. 2005

    Mechanical signals, IGF-I gene splicing, and muscle adaptation.

    Goldspink G. · Physiology (Bethesda, Md.)

    Cited by: MGF and PEG-MGF
  169. 2005

    Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.

    Robinson LR, Fitzgerald NC, Doughty DG, et al. · International journal of cosmetic science

  170. 2005

    Why most published research findings are false.

    Ioannidis JP. · PLoS medicine

    The 2022 correction adds missing parentheses in an equation in Table 2. This guide does not reproduce that equation; use the corrected table for calculations. View notice

  171. 2004

    Gonadotropin-releasing hormone receptors.

    Millar RP, Lu ZL, Pawson AJ, et al. · Endocrine reviews

  172. 2004

    Myostatin mutation associated with gross muscle hypertrophy in a child.

    Schuelke M, Wagner KR, Stolz LE, et al. · The New England journal of medicine

    Cited by: Follistatin-344
  173. 2004

    Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.

    Romani L, Bistoni F, Gaziano R, et al. · Blood

  174. 2004

    Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.

    Bock-Marquette I, Saxena A, White MD, et al. · Nature

    Cited by: Thymosin Beta-4
  175. 2004

    Thymosins: chemistry and biological properties in health and disease.

    Goldstein AL, Badamchian M. · Expert opinion on biological therapy

    Cited by: Thymalin
  176. 2003Cited by 5 guides

    Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.

    Khavinson VKh, Bondarev IE, Butyugov AA. · Bulletin of experimental biology and medicine

  177. 2003Cited by 3 guides

    PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

    Molinoff PB, Shadiack AM, Earle D, et al. · Annals of the New York Academy of Sciences

  178. 2003

    Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage.

    Hill M, Goldspink G. · The Journal of physiology

    Cited by: MGF and PEG-MGF
  179. 2003

    Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.

    de Roux N, Genin E, Carel JC, et al. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: Kisspeptin
  180. 2003

    Peptides of pineal gland and thymus prolong human life.

    Khavinson VKh, Morozov VG. · Neuro endocrinology letters

    Cited by: Thymalin
  181. 2003

    The effect of topical tripeptide-copper complex on healing of ischemic open wounds.

    Canapp SO Jr, Farese JP, Schultz GS, et al. · Veterinary surgery : VS

    Cited by: GHK-Cu
  182. 2003

    The GPR54 gene as a regulator of puberty.

    Seminara SB, Messager S, Chatzidaki EE, et al. · The New England journal of medicine

    Cited by: Kisspeptin
  183. 2002Cited by 23 guides

    Peptides and Ageing.

    Khavinson VKh. · Neuro endocrinology letters

  184. 2002

    A synthetic hexapeptide (Argireline) with antiwrinkle activity.

    Blanes-Mira C, Clemente J, Jodas G, et al. · International journal of cosmetic science

  185. 2002

    CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

    Bodart V, Febbraio M, Demers A, et al. · Circulation research

    Cited by: Hexarelin
  186. 2002

    Molecular Biology of the Cell. Chapter 3: Proteins.

    Alberts B, Johnson A, Lewis J, et al. · Garland Science, 4th ed.; NCBI Bookshelf

  187. 2001Cited by 2 guides

    A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.

    Hashimoto Y, Niikura T, Tajima H, et al. · Proceedings of the National Academy of Sciences of the United States of America

    The 2001 correction fixes an accession identifier and limits what the discovery paper established about genomic origin and in-vivo peptide production. It is not a verdict on subsequent research. View notice

  188. 2001

    Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

    Murphy MG, Weiss S, McClung M, et al. · The Journal of clinical endocrinology and metabolism

  189. 2001

    Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.

    Heffernan MA, Thorburn AW, Fam B, et al. · International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity

    Cited by: AOD-9604
  190. 2001

    Regulation of myostatin activity and muscle growth.

    Lee SJ, McPherron AC. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: Follistatin-344
  191. 2001

    The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.

    Heffernan M, Summers RJ, Thorburn A, et al. · Endocrinology

    Cited by: AOD-9604
  192. 2001

    The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54.

    Kotani M, Detheux M, Vandenbogaerde A, et al. · The Journal of biological chemistry

    Cited by: Kisspeptin
  193. 2001

    The oxytocin receptor system: structure, function, and regulation.

    Gimpl G, Fahrenholz F. · Physiological reviews

    Cited by: Oxytocin
  194. 2001

    The somatomedin hypothesis: 2001.

    Le Roith D, Bondy C, Yakar S, et al. · Endocrine reviews

    Cited by: IGF-1 LR3
  195. 2000Cited by 2 guides

    The 500 Dalton rule for the skin penetration of chemical compounds and drugs.

    Bos JD, Meinardi MM. · Experimental dermatology

  196. 2000

    Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

    Wessells H, Gralnek D, Dorr R, et al. · Urology

  197. 2000

    LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

    De Yang, Chen Q, Schmidt AP, et al. · The Journal of experimental medicine

    Cited by: LL-37
  198. 2000

    Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.

    Wessells H, Levine N, Hadley ME, et al. · International journal of impotence research

    Cited by: Melanotan II
  199. 2000

    The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.

    Svensson J, Lall S, Dickson SL, et al. · The Journal of endocrinology

    Cited by: Ipamorelin
  200. 1999Cited by 5 guides

    Thymosin beta4 accelerates wound healing.

    Malinda KM, Sidhu GS, Mani H, et al. · The Journal of investigative dermatology

  201. 1999Cited by 2 guides

    Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

    Kojima M, Hosoda H, Date Y, et al. · Nature

  202. 1999

    Melanocortin receptors: perspectives for novel drugs.

    Wikberg JE. · European journal of pharmacology

    Cited by: PT-141
  203. 1999

    Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.

    Prakash A, Goa KL. · BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

    Cited by: Sermorelin
  204. 1998Cited by 6 guides

    Ipamorelin, the first selective growth hormone secretagogue.

    Raun K, Hansen BS, Johansen NL, et al. · European journal of endocrinology

  205. 1998Cited by 2 guides

    Growth hormone-releasing peptide (GHRP).

    Bowers CY. · Cellular and molecular life sciences : CMLS

    Cited by: GHRP-2, Hexarelin
  206. 1997

    Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

    McPherron AC, Lawler AM, Lee SJ. · Nature

    Cited by: Follistatin-344
  207. 1996Cited by 2 guides

    Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.

    Dorr RT, Lines R, Levine N, et al. · Life sciences

  208. 1996

    KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.

    Lee JH, Miele ME, Hicks DJ, et al. · Journal of the National Cancer Institute

    A correction is linked in PubMed. The full correction text was not verified in this review, so its effect on the cited claims remains unresolved. View notice

    Cited by: Kisspeptin
  209. 1996

    The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.

    Gudmundsson GH, Agerberth B, Odeberg J, et al. · European journal of biochemistry

    Cited by: LL-37
  210. 1995

    Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

    Patchett AA, Nargund RP, Tata JR, et al. · Proceedings of the National Academy of Sciences of the United States of America

  211. 1995

    FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.

    Agerberth B, Gunne H, Odeberg J, et al. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: LL-37
  212. 1995

    The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis.

    Lijesen GK, Theeuwen I, Assendelft WJ, et al. · British journal of clinical pharmacology

    Cited by: HCG
  213. 1993

    A pentapeptide from type I procollagen promotes extracellular matrix production.

    Katayama K, Armendariz-Borunda J, Raghow R, et al. · The Journal of biological chemistry

  214. 1992

    Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

    Eng J, Kleinman WA, Singh L, et al. · The Journal of biological chemistry

  215. 1991

    Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.

    Tomas FM, Knowles SE, Owens PC, et al. · The Journal of endocrinology

    Cited by: IGF-1 LR3
  216. 1991

    Gonadotropin-releasing hormone and its analogues.

    Conn PM, Crowley WF Jr. · The New England journal of medicine

  217. 1989

    Thymulin, a zinc-dependent hormone.

    Bach JF, Dardenne M. · Medical oncology and tumor pharmacotherapy

    Cited by: Thymulin
  218. 1984Cited by 2 guides

    On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

    Bowers CY, Momany FA, Reynolds GA, et al. · Endocrinology

  219. 1984

    Delta-sleep-inducing peptide (DSIP): a review.

    Graf MV, Kastin AJ. · Neuroscience and biobehavioral reviews

    Cited by: DSIP
  220. 1984

    IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983.

    . · European journal of biochemistry

    A 1993 correction is recorded. The official online recommendations incorporate published corrections and are available through the link below. The separate 1993 notice has not been reviewed in full here. View notice

  221. 1984

    The Nobel Prize in Chemistry 1984 — Robert Bruce Merrifield.

    The Nobel Foundation. · NobelPrize.org

  222. 1983

    Glutathione.

    Meister A, Anderson ME. · Annual review of biochemistry

    Cited by: Glutathione
  223. 1982

    Contribution of zinc and other metals to the biological activity of the serum thymic factor.

    Dardenne M, Pléau JM, Nabarra B, et al. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: Thymulin
  224. 1981

    The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.

    Schneider-Helmert D, Schoenenberger GA. · Experientia

    Cited by: DSIP
  225. 1979

    Increase in lifespan of rats following polypeptide pineal extract treatment.

    Dilman VM, Anisimov VN, Ostroumova MN, et al. · Experimentelle Pathologie

  226. 1979

    The chemistry and biology of thymosin. II. Amino acid sequence analysis of thymosin alpha1 and polypeptide beta1.

    Low TL, Goldstein AL. · The Journal of biological chemistry

  227. 1978

    Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.

    Belchetz PE, Plant TM, Nakai Y, et al. · Science (New York, N.Y.)

  228. 1977

    Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.

    Schoenenberger GA, Monnier M. · Proceedings of the National Academy of Sciences of the United States of America

    Cited by: DSIP
  229. 1977

    Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

    Goldstein AL, Low TL, McAdoo M, et al. · Proceedings of the National Academy of Sciences of the United States of America

  230. 1970

    Polypeptide with broad biological activity: isolation from small intestine.

    Said SI, Mutt V. · Science (New York, N.Y.)

  231. 1963

    Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide.

    Merrifield RB. · Journal of the American Chemical Society

  232. 1953;75(19):4879–4880Cited by 2 guides

    The synthesis of an octapeptide amide with the hormonal activity of oxytocin.

    du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S. · J Am Chem Soc

  233. 1922

    Pancreatic Extracts in the Treatment of Diabetes Mellitus.

    Banting FG, Best CH, Collip JB, et al. · Canadian Medical Association journal

  234. 1902

    The mechanism of pancreatic secretion.

    Bayliss WM, Starling EH. · The Journal of physiology

Each record links to the guides that cite it. Read the original source and the guide in context; the presence of a reference does not independently validate a guide's claims.

Browse the research library →

Research Use Only. All information on this site is provided for educational and laboratory research purposes only. Nothing on this site constitutes medical advice or a therapeutic claim.